PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Net margin 2022–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) net profit margin by fiscal year — reported net income divided by reported revenue.
-1615.8%FY2025 · since FY2022: -359.4% → -1615.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1615.8% | -849.0 pp |
| FY2024 | -766.9% | -210.7 pp |
| FY2023 | -556.2% | -196.8 pp |
| FY2022 | -359.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PVCT financial trends
PVCT RevenuePVCT Net incomePVCT Gross profitPVCT Gross marginPVCT Operating incomePVCT Operating marginPVCT Operating cash flowPVCT Free cash flowPVCT Capital expendituresPVCT Return on equityPVCT Stock buybacksPVCT Dividends paidPVCT Total assetsPVCT Total liabilitiesPVCT Shareholders’ equityPVCT overview →